US Bancorp’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.03K | Sell |
533
-37
| -6% | -$418 | ﹤0.01% | 3575 |
|
|
2025
Q1 | $6.58K | Buy |
+570
| New | +$6.58K | ﹤0.01% | 3560 |
|
|
2022
Q4 | – | Sell |
-2,984
| Closed | -$43K | – | 4191 |
|
|
2022
Q3 | $43K | Buy |
+2,984
| New | +$43K | ﹤0.01% | 2624 |
|
|
2021
Q3 | – | Sell |
-113
| Closed | -$3K | – | 4087 |
|
|
2021
Q2 | $3K | Buy |
+113
| New | +$3K | ﹤0.01% | 3710 |
|